Aptamer-Targeted RNAi for HIV-1 Therapy

Methods in Molecular Biology

Volumn 721, Issue , 2011, Pages 355-371

  Zhou, Jiehua ^b   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

Anti gp120 aptamer; Aptamer targeted RNAi; Cell type specific delivery system; RNA interference

Indexed keywords

APTAMER; GAG PROTEIN; SMALL INTERFERING RNA;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; CELL SURVIVAL; CHO CELL; CONFOCAL MICROSCOPY; CRICETULUS; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR SPACE; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL; VIRUS REPLICATION;

ANIMALS; APTAMERS, NUCLEOTIDE; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HIV CORE PROTEIN P24; HIV-1; HUMANS; INTRACELLULAR SPACE; MICROSCOPY, CONFOCAL; MOLECULAR TARGETED THERAPY; ORGAN SPECIFICITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960054396     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-037-9_22     Document Type: Chapter

References (17)

1. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–11.
2. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25–33.
3. Castanotto, D., and Rossi, J. J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426–33.
4. Kim, D. H., and Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet 8, 173–84.
5. de Fougerolles, A., Vornlocher, H. P., Maraganore, J., and Lieberman, J. (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6, 443–53.
6. Song, E., Lee, S. K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., and Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9, 347–51.
7. Scherer, L., Rossi, J. J., and Weinberg, M. S. (2007) Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther 14, 1057–64.
8. Martinez, M. A. (2009) Progress in the therapeutic applications of siRNAs against HIV-1. Methods Mol Biol 487, 343–68.
9. Tsygankov, A. Y. (2009) Current developments in anti-HIV/AIDS gene therapy. Curr Opin Investig Drugs 10, 137–49.
10. Podlekareva, D., Mocroft, A., Dragsted, U. B., Ledergerber, B., Beniowski, M., Lazzarin, A., Weber, J., Clumeck, N., Vetter, N., Phillips, A., and Lundgren, J. D. (2006) Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis 194, 633–41.
11. Kilby, J. M., and Eron, J. J. (2003) Novel therapies based on mechanisms of HIV-1 cell entry. N Engl J Med 348, 2228–38.
12. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648–59.
13. Wyatt, R., and Sodroski, J. (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884–8.
14. Zhou, J., Li, H., Li, S., Zaia, J., and Rossi, J. J. (2008) Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16, 1481–9.
15. Zhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R., and Rossi, J. J. (2009) Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res 37, 3094–109.
16. Weiss, C. D., and White, J. M. (1993) Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J Virol 67, 7060–6.
17. Vodicka, M. A., Goh, W. C., Wu, L. I., Rogel, M. E., Bartz, S. R., Schweickart, V. L., Raport, C. J., and Emerman, M. (1997) Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 233, 193–8.